These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups.
Corporate investing and partnering has really taken off over the last few years as pharma and medical device companies have opened their doors and wallets to find innovation outside of their four walls.
A new analysis from CB Insights identifies the big healthcare corporations that have done the most deals and made the most acquisitions in healthcare over the past three years. In the count, CB Insights included acquisitions and investments in device, pharmaceutical and information technology companies who focus strictly on the healthcare industry.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
On the acquisition front, GE Healthcare led the way with 10 deals, including ultrasound repair company Unisys Medical Technologies, EMR and practice management software maker MedPlexus and Brazilian patient monitoring company Omnimed.
Novo Group, topped the list of corporate investors, investing in early-stage companies like anemia drug developer Akebia Therapeutics and PTC Therapeutics through Novo Ventures.
Here are the rankings of companies’ combined investments and acquisitions, based data since the start of 2010:
- Novo Group (NYSE:NVO) 51 investments, 1 acquisition
- Johnson & Johnson (NYSE:JNJ) 41 investments, 3 acquisitions
- Novartis (NYSE:NVS) 30 investments, 1 acquisition
- GlaxoSmithKline (NYSE:GSK) 34 investments, 4 acquisitions
- Pfizer (NYSE:PFE) 23 investments, 7 acquisitions
- General Electric (NYSE:GE) 18 investments, 10 acquisitions
- Roche Holding 16 investments, 4 acquisitions
- Medtronic (NYSE:MDT) 14 investments, 6 acquisitions
- Eli Lilly & Co. (NYSE:LLY) 16 investments, 3 acquisitions
- Kaiser Permanente 19 investments, 0 acquisitions
